A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation

Human natural killer (NK) cells express inhibitory (p58) or activatory (p50) receptors for HLA‐C alleles. Here, we describe a novel member of the p58/p50 family that is expressed by a subset of NK cells in about one third of donors. This molecule, termed p50.3, mediates NK cell triggering as revealed by the induction of intracellular free calcium mobilization, cytokine release and cytotoxicity. In addition, anti‐p50.3 monoclonal antibody (mAb) induced a selective, strong proliferation of p50.3+ NK cells in peripheral blood lymphocytes. Although p50.3 molecules do not appear to display an obvious HLA class I specificity, they are usually coexpressed with known inhibitory receptors for HLA class I alleles. mAb‐mediated cross‐linking of these receptors leads to inhibition of the anti‐p50.3 mAb‐induced NK cell activation and proliferation. Surface p50.3 molecules are glycoproteins of ∼ 55–58 kDa which, upon deglycosylation, display a relative molecular mass of 36 kDa, similar to that of deglycosylated (activatory) p50 receptors. Analysis of the two‐dimensional peptide maps of the 50.3 molecules revealed a high homology with the other HLA‐C‐specific p58/p50 receptors. The use of a set of oligodeoxynucleotide primers, previously shown to amplify the activatory (p50) forms of HLA‐C‐specific receptors, consistently amplified in p50.3+ clones a cDNA sequence termed KKA3. This sequence belongs to the p58/p50 multigene family, that encodes for a transmembrane protein specifically stained by anti‐p50.3 mAb in cell transfectants. Similar to p50 molecules, the KKA3‐encoded molecules are characterized by two extracellular immunoglobulin‐like domains, by the presence of a lysine in the transmembrane region and a short (39 amino acids) cytoplasmic tail which does not contain immune receptor tyrosine‐based activation motifs (ITAM)‐like sequences.

[1]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Biassoni,et al.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.

[3]  W. Seaman,et al.  The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. , 1993, Annual review of immunology.

[4]  R. Biassoni,et al.  Receptors for HLA class-I molecules in human natural killer cells. , 1996, Annual review of immunology.

[5]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[6]  U. Koszinowski,et al.  Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment , 1992, The Journal of experimental medicine.

[7]  J. Drazen,et al.  Sorting out the cytokines of asthma , 1996, The Journal of experimental medicine.

[8]  E. Ciccone,et al.  The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 ζ chain, FcϵRI γ chain and the p56lck kinase , 1994 .

[9]  D. Kaufman,et al.  Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[11]  G. Pantaleo,et al.  A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function , 1990, The Journal of experimental medicine.

[12]  E. Ciccone,et al.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities , 1993, The Journal of experimental medicine.

[13]  E. Ciccone,et al.  Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. , 1993, Blood.

[14]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[15]  Eric O Long,et al.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.

[16]  A. Amoroso,et al.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) , 1992, The Journal of experimental medicine.

[17]  L. Moretta,et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.

[18]  Eric O Long,et al.  Peptide specificity in the recognition of MHC class I by natural killer cell clones , 1995, Science.

[19]  A. Amoroso,et al.  Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[21]  D. Raulet,et al.  Natural killer cell receptors: The offs and ons of NK cell recognition , 1995, Cell.

[22]  F. Garrido,et al.  HLA class I antigens in human tumors. , 1995, Advances in cancer research.

[23]  J. Maryanski,et al.  "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Ciccone,et al.  Human natural killer cells: origin, clonality, specificity, and receptors. , 1994, Advances in immunology.